MIS-C Comparative Effectiveness Study

计划入组 73 人 · 首次发布于 2021 年 5 月 24 日

Cardiovascular Assessment 5 Years After MIS-C

计划入组 90 人 · 首次发布于 2026 年 6 月 22 日

Immun Response in Children With MIS-C

计划入组 20 人 · 首次发布于 2021 年 9 月 22 日

MIS-416

C 135LS/C 144LS

Lanatoside C

C₄₉H₇₆O₂₀

MIS IMPLANTS TECHNOLOGIES LTD

Israel

C & C Oxygen Company

United States

Buchanan C Michael

United States

Experimental Celiac Drug Shows Promise in Treating Children with Post-COVID Inflammatory Syndrome

NCI's SeroNet Studies Immune Responses to COVID-19 and Vaccines

LANCE Trial Shows Feasibility of Minimally Invasive Surgery for Advanced Ovarian Cancer After Chemotherapy